FHIR IG analytics34 resources
By Realm
| Package | Identity | Name/Title | Status | FMM | WG | Date | Realm | Context | Modifier | Type |
|---|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.uv.ebm | StructureDefinition-relatesto-classifier.json | RelatesToClassifier | trial-use | 1 | cds | 2026-02 | uv | Context: Evidence.relatesTo,Composition.relatesTo,Citation.relatesTo,ArtifactAssessment.relatesTo,EvidenceVariable.relatesTo,ResearchStudy.relatesTo | Type:CodeableConcept | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-artifact-assessment-date-as-rating.json | ArtifactAssessmentDateAsRating | trial-use | 1 | cds | 2026-02 | uv | Context: ArtifactAssessment.content | Type:dateTime | Mod:0 |
| hl7.fhir.uv.clinical-study-protocol | StructureDefinition-m11-protocol-amendment.json | M11_ProtocolAmendment | trial-use | 1 | brr | 2026-02 | uv | Context: ResearchStudy | Type:complex | Mod:0 |
| hl7.fhir.uv.pharmaceutical-research-protocol | StructureDefinition-protocol-amendment.json | M11_ProtocolAmendment | trial-use | 1 | brr | 2025-08 | uv | Context: ResearchStudy | Type:complex | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-study-amendment.json | ResearchStudyStudyAmendment | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:complex | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-statistic-model-expression.json | StatisticModelExpression | trial-use | 1 | cds | 2026-02 | uv | Context: Evidence.statistic | Type:Expression | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-cite-as.json | CiteAs | trial-use | 1 | cds | 2026-02 | uv | Context: Group,ArtifactAssessment,Evidence,EvidenceVariable,PlanDefinition,List,CodeSystem,ValueSet,ResearchStudy,ActivityDefinition | Type:markdown | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-guideline-registration.json | GuidelineRegistration | trial-use | 1 | cds | 2026-02 | uv | Context: Composition | Type:complex | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-evidence-variable-handling-detail.json | EvidenceVariableHandlingDetail | trial-use | 1 | cds | 2026-02 | uv | Context: Evidence.statistic.modelCharacteristic.variable,EvidenceVariable | Type:CodeableConcept | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-is-low-intervention-trial.json | ResearchStudyIsLowInterventionTrial | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:boolean | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-is-rare-disease.json | ResearchStudyIsRareDisease | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy.condition | Type:boolean | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-excluded-study.json | ResearchStudyExcludedStudy | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:Reference | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-included-study.json | ResearchStudyIncludedStudy | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:Reference | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-systematic-review-eligibility-criteria.json | ResearchStudySystematicReviewEligibilityCriteria | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:Reference | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-search-strategy.json | ResearchStudySearchStrategy | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:Reference | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-sae-reporting-method.json | ResearchStudySaeReportingMethod | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:string | Mod:0 |
| hl7.fhir.uv.clinical-study-protocol | StructureDefinition-narrative-elements.json | Narrative Elements | trial-use | 2 | brr | 2026-02 | uv | Context: ResearchStudy | Type:Reference | Mod:0 |
| hl7.fhir.uv.pharmaceutical-research-protocol | StructureDefinition-narrative-elements.json | Narrative Elements | trial-use | 2 | brr | 2025-08 | uv | Context: ResearchStudy | Type:Reference | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-number-of-studies-identified.json | ResearchStudyNumberOfStudiesIdentified | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:unsignedInt | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-number-of-studies-included.json | ResearchStudyNumberOfStudiesIncluded | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:unsignedInt | Mod:0 |
| hl7.fhir.uv.clinical-study-protocol | StructureDefinition-m11-amendment-detail.json | M11_AmendmentDetails | trial-use | 1 | brr | 2026-02 | uv | Context: Element | Type:complex | Mod:0 |
| hl7.fhir.uv.pharmaceutical-research-protocol | StructureDefinition-protocol-amendment-detail.json | ResearchStudyStudyAmendmentDetails | trial-use | 1 | brr | 2025-08 | uv | Context: Element | Type:complex | Mod:0 |
| hl7.fhir.uv.clinical-study-protocol | StructureDefinition-m11-amendment-scope-impact.json | M11_AmendmentScopeImpact | trial-use | 1 | brr | 2026-02 | uv | Context: Element | Type:complex | Mod:0 |
| hl7.fhir.uv.pharmaceutical-research-protocol | StructureDefinition-ResearchStudyStudyAmendmentScopeImpact.json | ResearchStudyStudyAmendmentScopeImpact | trial-use | 1 | brr | 2025-08 | uv | Context: Element | Type:complex | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-relative-outcome-importance.json | RelativeOutcomeImportance | trial-use | 1 | cds | 2026-02 | uv | Context: Evidence.variableDefinition | Type:Reference | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-relates-to-with-quotation.json | RelatesToWithQuotation | trial-use | 1 | cds | 2026-02 | uv | Context: Evidence.relatesTo,Citation.relatesTo,ArtifactAssessment.relatesTo,EvidenceVariable.relatesTo,ArtifactAssessment.content.component.relatesTo,ArtifactAssessment.content.relatesTo,ResearchStudy.relatesTo | Type:markdown | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-research-study-sponsor-confidentiality-statement.json | ResearchStudySponsorConfidentialityStatement | trial-use | 1 | cds | 2026-02 | uv | Context: ResearchStudy | Type:string | Mod:0 |
| hl7.fhir.uv.clinical-study-protocol | StructureDefinition-m11-confidentiality-statement.json | M11_ConfidentialityStatement | draft | 1 | brr | 2026-02 | uv | Context: ResearchStudy | Type:string | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-artifact-assessment-compared.json | ArtifactAssessmentCompared | trial-use | 1 | cds | 2026-02 | uv | Context: ArtifactAssessment | Type:Reference,canonical,uri | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-statistic-model-include-if.json | StatisticModelIncludeIf | trial-use | 1 | cds | 2026-02 | uv | Context: Evidence.statistic.modelCharacteristic.variable,Evidence.statistic.modelCharacteristic | Type:complex | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-artifact-recorder.json | ArtifactRecorder | trial-use | 1 | cds | 2026-02 | uv | Context: Resource | Type:ContactDetail | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-number-analyzed.json | NumberAnalyzed | trial-use | 1 | cds | 2026-02 | uv | Context: Evidence.statistic.sampleSize | Type:unsignedInt | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-artifact-publication-status.json | ArtifactPublicationStatus | trial-use | 1 | cds | 2026-02 | uv | Context: Resource | Type:CodeableConcept | Mod:0 |
| hl7.fhir.uv.ebm | StructureDefinition-characteristic-timing.json | CharacteristicTiming | trial-use | 1 | cds | 2026-02 | uv | Context: EvidenceVariable,PlanDefinition.action,ActivityDefinition | Type:complex | Mod:0 |
FHIR
FHIRsmith